News

Daré Bioscience Secures $15 Million Investment for Innovation

Daré Bioscience Secures $15 Million Investment for Innovation

Daré Bioscience Secures Significant Funding for Women's Health Initiatives

Daré Bioscience, Inc. (NASDAQ: DARE), renowned for its commitment to enhancing women’s health, has announced a pivotal $15 million common stock purchase agreement with Lincoln Park Capital Fund, LLC, a prominent institutional investor. This agreement aims to bolster Daré's development of innovative products tailored for women's health and wellbeing.

Details of the Stock Purchase Agreement

This strategic agreement allows Daré to sell up to $15 million worth of its common stock to LPC over the next 24 months. The execution of this deal is contingent upon the filing and approval of a registration statement by the SEC, which will enable LPC to resell the shares purchased under this agreement. Importantly, Daré retains the authority to dictate when and how much stock it sells, providing the company with valuable control over its capital-raising efforts.

How This Funding Supports Daré's Development Programs

Sabrina Martucci Johnson, President and CEO of Daré Bioscience, expressed excitement about this collaboration with LPC. She noted that the funding from a prior arrangement in 2020 significantly contributed to the development of XACIATO, Daré's FDA-approved vaginal gel. Johnson emphasized that similar funding could facilitate the advancement of multiple investigational products, particularly Sildenafil Cream, 3.6%. This innovative treatment is poised to be a first-in-category solution for female sexual arousal disorder, a trail Daré is navigating with ongoing discussions with the FDA regarding the design of its pivotal Phase 3 clinical trial.

Understanding the Conditions of the Agreement

As outlined in the purchase agreement, LPC commits to refraining from any actions such as short selling or hedging involving Daré’s common stock. The agreement is highly favorable, allowing Daré to use proceeds without restrictions and without incurring additional costs if they decide to terminate the agreement at their discretion.

About Daré Bioscience

Daré Bioscience is dedicated to pioneering products that address a wide array of women’s health issues, focusing on areas such as contraception, vaginal health, reproductive health, and menopause. With a diverse portfolio, the company aims to improve health outcomes and expand treatment options for women globally.

Innovative Product Portfolio

The company has introduced XACIATO, the first FDA-approved product for treating bacterial vaginosis in women. This product is pivotal in Daré’s ongoing mission to advance women's health and is marketed under a global license agreement with Organon. Furthermore, Daré is developing several other promising candidates, like Ovaprene, a hormone-free contraceptive, and DARE-HRT1, an advanced therapy for menopausal women.

Recognition and Leadership

Daré's leadership has received accolades within the pharmaceutical community, being recognized for its commitment to innovation and advocacy for women’s health. The CEO was honored in 2023 among the most influential figures in biopharma, showcasing Daré’s commitment to driving change in this crucial area of healthcare.

Frequently Asked Questions

What is the purpose of the agreement with Lincoln Park Capital?

The agreement allows Daré to raise up to $15 million to support the development of its women's health product portfolio without the immediate need for traditional equity financing.

What products are part of Daré’s pipeline?

Daré’s portfolio includes initiatives like Sildenafil Cream for female sexual arousal disorder and Ovaprene, a novel contraceptive method.

How does the funding impact Daré's research programs?

The funding will provide Daré the necessary capital to conduct clinical trials, such as the Phase 3 study for Sildenafil Cream, essential for progressing their product development.

What is XACIATO?

XACIATO is an FDA-approved vaginal gel for treating bacterial vaginosis, marking a significant entry for Daré in the women's health market.

How has Daré been recognized in the industry?

Daré has received accolades including top rankings in the San Diego Business Journal’s Best Places to Work Awards and recognition for its impactful leadership.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sidus Gains Argotec Order, but Investors Need the Math

Updated Category News Views 92

A Real Customer Signal, Minus the Revenue Figure An updated image is the least interesting detail in this release. Sidus Space has landed a purchase order from Argotec Group to manufacture cable assemblies for the HAWK satellite platform, with delivery expected in the first quarter of 2027. That is a legitimate operational win for NASDAQ:SIDU. It brings in a new...

Continue Reading
D-Wave Investors Face December 15 Lead Plaintiff Clock

Updated Category News Views 94

Quantum dreams met a very earthly spreadsheet problem at D-Wave this summer. The proposed securities class action against D-Wave Quantum Inc. puts a hard date on the issue for investors who bought shares between February 26 and August 25, 2026: December 15, 2026 is the deadline to seek lead-plaintiff status. That does not mean every holder needs to march into court. It...

Continue Reading
AI Governance Is Becoming Enterprise Infrastructure

Updated Category News Views 52

Governance Has Finally Reached the Engine Room Enterprise AI is no longer a shiny pilot parked in some innovation lab; it is creeping into business-critical work, and that changes the argument entirely. Frost & Sullivan’s latest analysis makes a sensible point that too many executives still resist: AI governance is becoming a strategic operating capability, not merely a...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 28

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 71

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading
Branch's Fast 500 Rank Signals Payroll Platform Reach

Updated Category News Views 89

Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 81

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Trade Secret Damages Turn on Corporate Intent Evidence

Updated Category News Views 101

Suspicion may rattle a courtroom, but it apparently does not always loosen the jury’s purse strings. That is the useful, slightly sobering takeaway from DOAR’s new national study on damages in trade secret disputes, released November 20, 2026. Jurors, according to the report, draw a meaningful line between an employee carrying experience to a new job and a company...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 43

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
Story Cannabis Bets on Neighborly Thanksgiving Outreach

Updated Category News Views 67

A frozen turkey is not a grand strategy deck, thank goodness; it is dinner for a household that might be feeling the squeeze. Story Cannabis plans to hand out 840 of them on Tuesday, Nov. 24, splitting the giveaway between Columbus and Cleveland with former Ohio State and Dallas Cowboys running back Michael Wiley joining employees and volunteers. In a cannabis business...

Continue Reading

Top 5 Most Recently Viewed Articles

PAPZIMEOS Emerges as the Go-To Treatment for RRP Patients

Updated Category News Views 104

PAPZIMEOS: A Promising New Standard for RRP Therapy PAPZIMEOS (zopapogene imadenovec) has gained recognition as an innovative treatment for adults suffering from recurrent respiratory papillomatosis (RRP). This breakthrough comes following the publication of a consensus paper authored by 16 leading experts in the field. Sponsored by the Recurrent Respiratory...

Continue Reading
Ollie's Bargain Outlet Reports Encouraging Q2 Results

Updated Category News Views 159

Ollie's Bargain Outlet Achieves Strong Q2 Performance Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) has made headlines recently as its shares experience fluctuations in the market. The company revealed impressive second-quarter adjusted earnings per share of 99 cents, surpassing analyst expectations of 94 cents. The quarterly sales reached $679.556 million, marking...

Continue Reading
Fivecast Introduces Groundbreaking Discovery Solution for OSINT

Updated Category News Views 184

Fivecast Unveils Discovery Solution to Combat Global Threats In today's rapidly evolving landscape of global threats, Fivecast, a prominent provider of advanced open-source intelligence (OSINT) solutions, has rolled out an innovative Discovery solution designed to assist analysts and investigators in both government and corporate settings. By elevating the speed and...

Continue Reading
Zen Technologies USA Advances Military Training with AI Simulations

Updated Category News Views 224

Zen Technologies USA Showcases Cutting-Edge AI Simulations Zen Technologies USA is set to revolutionize military training capabilities with its next-generation AI-enabled live and virtual simulation solutions. By enabling high-fidelity training for ground and naval forces, these innovations aim to accelerate the readiness of military units while significantly reducing...

Continue Reading
Sectra and Siemens Healthineers Transform Radiology Workflows

Updated Category News Views 494

Revolutionizing Radiology with Innovative Integrations International medical imaging IT and cybersecurity company Sectra (STO: SECT B) and Siemens Healthineers AG have formed a pivotal collaboration aimed at enhancing diagnostic capabilities in the radiology field. This initiative seeks to improve patient care by enabling seamless access to advanced imaging technologies....

Continue Reading